137 related articles for article (PubMed ID: 37655083)
1. Long-Term Survival in Patients with Cancers: Surveillance, epidemiology and end results-based analysis.
Sakr RA; Nasr AA; Zineldin EI; Gouda MA
Sultan Qaboos Univ Med J; 2023 Aug; 23(3):344-350. PubMed ID: 37655083
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
4. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
[TBL] [Abstract][Full Text] [Related]
5. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
8. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
9. Conditional relative survival among long-term survivors of adolescent and young adult cancers.
Anderson C; Smitherman AB; Nichols HB
Cancer; 2018 Jul; 124(14):3037-3043. PubMed ID: 29742278
[TBL] [Abstract][Full Text] [Related]
10. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
[TBL] [Abstract][Full Text] [Related]
11. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.
Tai P; Yu E; Cserni G; Vlastos G; Royce M; Kunkler I; Vinh-Hung V
BMC Cancer; 2005 May; 5():48. PubMed ID: 15904508
[TBL] [Abstract][Full Text] [Related]
12. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
13. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program.
Gloeckler Ries LA; Reichman ME; Lewis DR; Hankey BF; Edwards BK
Oncologist; 2003; 8(6):541-52. PubMed ID: 14657533
[TBL] [Abstract][Full Text] [Related]
14. The "Classification Pendulum" of Stage I Colorectal Cancer: A National Level Analysis of the Survival Difference Between T1 and T2 Colorectal Cancer.
Allievi N; Goffredo P; Freischlag KW; Utria AF; Cromwell JW; Pisano M; Poiasina E; Hassan I
Dis Colon Rectum; 2022 Apr; 65(4):505-518. PubMed ID: 34310516
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis.
Brenner H
Lancet; 2002 Oct; 360(9340):1131-5. PubMed ID: 12387961
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
17. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis.
Dubecz A; Gall I; Solymosi N; Schweigert M; Peters JH; Feith M; Stein HJ
J Thorac Oncol; 2012 Feb; 7(2):443-7. PubMed ID: 22173700
[TBL] [Abstract][Full Text] [Related]
18. Benefits of marriage on relative and conditional relative cancer survival differ between males and females in the USA.
Merrill RM; Johnson E
J Cancer Surviv; 2017 Oct; 11(5):578-589. PubMed ID: 28770444
[TBL] [Abstract][Full Text] [Related]
19. The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.
Feuer EJ; Rabin BA; Zou Z; Wang Z; Xiong X; Ellis JL; Steiner JF; Cynkin L; Nekhlyudov L; Bayliss E; Hankey BF
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):265-74. PubMed ID: 25417240
[TBL] [Abstract][Full Text] [Related]
20. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality.
Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L
BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]